申请人:THE UNIVERSITY OF TOKYO
公开号:US20140364642A1
公开(公告)日:2014-12-11
[Problem] Provision of a novel compound having read-through activity and a drug for the treatment of nonsense mutation-type disease containing this compound.
[Solution] A compound represented by the following general formula (1):
and a pharmaceutical composition containing this compound.
一种具有读穿活性的新化合物以及包含该化合物的用于治疗无义突变型疾病的药物。
一种由以下一般式(1)表示的化合物:
以及含有该化合物的药物组合物。